Patents by Inventor Alessandro Mordini

Alessandro Mordini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs activated by RNA-dependent DNA-polymerases
    Patent number: 8110676
    Abstract: The invention provides prodrugs activated by RNA-dependent DNA-polymerases, and methods for treating hematological tumors, blood, and blood derivatives from patients affected by retroviral infections by administering the prodrugs. The invention also provides methods for the preparation of pharmaceutical compositions containing the prodrugs.
    Type: Grant
    Filed: August 2, 2005
    Date of Patent: February 7, 2012
    Assignee: Protera S.R.L.
    Inventors: Ivano Bertini, Claudio Luchinat, Alessandro Quattrone, Massimo Calamante, Alessandro Mordini
  • Prodrugs Activated by Rna-Dependent Dna-Polymerases
    Publication number: 20080300215
    Abstract: Herein described are prodrugs activated by RNA-dependent DNA-polymerases, such as telomerase and retroviral reverse transcriptases, their use for the treatment of haematological tumours and of blood and blood derivatives from patients affected by retroviral infections, and their use for the preparation of pharmaceutical compositions, to be used for the treatment of solid tumours, of precancerous states and of diseases caused by infection with retroviruses.
    Type: Application
    Filed: August 2, 2005
    Publication date: December 4, 2008
    Applicant: PROTERA S.R.L.
    Inventors: Ivano Bertini, Claudio Luchinat, Alessandro Quattrone, Massimo Calamante, Alessandro Mordini